During the past decade, Sprim ALS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sprim ALS" #1 sponsor was "Bio-K Plus International Inc." with 1 trials, followed by "Fonterra Research Centre" with 1 trials sponsored, "NewChapter, Inc." with 1 trials sponsored, "Renew Life Formulas Inc" with 1 trials sponsored and "Sprim Advanced Life Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sprim ALS" #1 collaborator was "Sprim Advanced Life Sciences" with 3 trials as a collaborator, "DuPont Nutrition and Health" with 1 trials as a collaborator and "The National Institute of Probiotics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sprim ALS" are "Constipation" (1 trials), "Functional Constipation" (1 trials), "Irritable Bowel Syndrome" (1 trials), "Prediabetes" (1 trials) and "Recurrent Gastrointestinal Symptoms" (1 trials). Many other conditions were trialed in "Sprim ALS" in a lesser frequency.

Most popular intervention types in "Sprim ALS" are "Dietary Supplement" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "B. lactis HN019" (1 trials), "Blood Sugar Take Care" (1 trials), "High dose Multistrain probiotic, 100 billion cfu/day" (1 trials) and "L. acidophilus CL1285® + L. casei LBC80R® + L. rhamnosus CLR2®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sprim ALS" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Sprim ALS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sprim ALS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sprim ALS, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".